J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kesari, S.
Right arrow Articles by Fraser, N. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kesari, S.
Right arrow Articles by Fraser, N. W.
Agricola
Right arrow Articles by Kesari, S.
Right arrow Articles by Fraser, N. W.

Journal of General Virology, Vol 79, 525-536, Copyright © 1998 by Society for General Microbiology

ARTICLES

A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system

S Kesari, TM Lasner, KR Balsara, BP Randazzo, VM Lee, JQ Trojanowski and NW Fraser
The Wistar Institute, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

Herpes simplex virus type 1 (HSV-1) variant 1716 is deleted in the gene encoding ICP34.5 and is neuroattenuated after intracranial inoculation of mice. Although the mechanism of attenuation is unclear, this property has been exploited to eliminate experimental brain tumours. Previously, it was shown that infectious 1716 was recoverable for up to 3 days after intracranial inoculation suggesting that there may be limited replication in the central nervous system (CNS). Here it is demonstrated that 1716 replicates in specific cell types (predominantly CNS ependymal cells) of BALB/c mice, using immunohistochemical, immunofluorescence, in situ hybridization and virus titration studies. While 1716-infected mice exhibited no overt signs of encephalitis, histological analysis showed a persistent loss of the ependymal lining. Thus, although ICP34.5-deficient viruses are neuroattenuated, they do retain the ability to replicate in and destroy the ependyma of the murine CNS. A detailed understanding of the mechanism(s) of neuroattenuation and limited replication could lead to the rational design of safe HSV vectors for cancer and gene therapy in the CNS.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
P. C. Huszthy, D. Goplen, F. Thorsen, H. Immervoll, J. Wang, A. Gutermann, H. Miletic, and R. Bjerkvig
Oncolytic Herpes Simplex Virus Type-1 Therapy in a Highly Infiltrative Animal Model of Human Glioblastoma
Clin. Cancer Res., March 1, 2008; 14(5): 1571 - 1580.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. A. Campbell, M. Mulvey, I. Mohr, and M. Gromeier
Attenuation of Herpes Simplex Virus Neurovirulence with Picornavirus cis-Acting Genetic Elements
J. Virol., January 15, 2007; 81(2): 791 - 799.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. Sundaresan, W. D. Hunter, R. L. Martuza, and S. D. Rabkin
Attenuated, Replication-Competent Herpes Simplex Virus Type 1 Mutant G207: Safety Evaluation in Mice
J. Virol., April 15, 2000; 74(8): 3832 - 3841.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
R. Y. Chung, Y. Saeki, and E. A. Chiocca
B-myb Promoter Retargeting of Herpes Simplex Virus gamma 34.5 Gene-Mediated Virulence toward Tumor and Cycling Cells
J. Virol., September 1, 1999; 73(9): 7556 - 7564.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1998 by the Society for General Microbiology.